Clinical Indication Clause Samples
Clinical Indication. The NanoKnife System has received FDA clearance for the surgical ablation of soft tissue [510(k) Number: K150089]. It has not received clearance for the therapy or treatment of any specific disease or condition.
Clinical Indication. Initiation of a Phase I Clinical Trial: Seventy five thousand dollars ($75,000) Initiation of a Phase II Clinical Trial: One hundred thousand dollars ($100,000) Initiation of a Phase III Clinical Trial: Two hundred fifty thousand dollars ($250,000) First Commercial Sale of Licensed Product: Five hundred thousand dollars ($500,000)